R&D Pipeline

Phase:

Therapy:

Pipeline last updated 30 October 2014
Compound/indication Phase 1 Phase 2 Phase 3 Filed
N8-GP (NN7088)

Haemophilia A
N9-GP (NN7999)

Haemophilia B
Concizumab (mAb2021)

Haemophilia A and B
  •